Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573787
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste DisordersChristoph GrimmTerminatedNot Applicable
NCT07573787Terminated
Not Applicable
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Dis...Christoph Grimm
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07571967
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol University HospitalRecruitingNot Applicable
NCT07571967Recruiting
Not Applicable
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol Universi...
NCT07574112
Muscle Energy Technique With And Without Myofascial Release in Patients With Cervicogenic HeadacheUniversity of LahoreCompletedNot Applicable
NCT07574112Completed
Not Applicable
Muscle Energy Technique With And Without Myofascial Release in Patients With Cer...University of Lahore
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07572656
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaMuhammad Aamir LatifCompletedNot Applicable
NCT07572656Completed
Not Applicable
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preecl...Muhammad Aamir Latif
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572539
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility Index for Predicting Hypotension in Patients Undergoing Shoulder Arthroscopy in Beach Chair Position:Tanta UniversityActive Not Recruiting
NCT07572539Active Not Recruiting
—
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility...Tanta University
NCT07573033
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibular 3rd Molar Surgery.Liaquat College of Medicine and DentistryCompletedPhase 4
NCT07573033Completed
Phase 4
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibul...Liaquat College of Medici...
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
Result Breakdown
Not yet recruiting12 (60%)
Completed3 (15%)
Recruiting2 (10%)
Terminated1 (5%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 23 (15%)
Phase 42 (10%)